The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Adrenocortical carcinoma in the United States: Treatment utilization and prognostic factors
Abstract
BACKGROUND: Adrenocortical carcinoma (ACC) is a rare tumor with a relatively poor prognosis. The authors' objectives were to examine treatment utilization and factors associated with long-term survival after resection of ACC in a large, national, patient population. METHODS: Patients diagnosed with ACC from 1985 to 2005 were identified from the National Cancer Data Base (NCDB). Patient, tumor, treatment, and hospital factors associated with survival after resection were examined. RESULTS: For the current study, 3982 patients with ACC were identified. Median age at diagnosis was 55 years. Median tumor size was 13 cm. Of the patients with nodes examined, 26.5% had nodal metastases. Distant metastases were found on presentation in 21.6% of patients. A total of 57.4% of patients underwent surgical resection alone, whereas 16.0% underwent resection with adjuvant chemotherapy or radiation. A total of 19.4% had margin-positive resections. Treatment utilization remained unchanged from 1985 to 2005 (P = .28). Median follow-up was 24 months. Overall 5-year survival for all patients who underwent resection was 38.6% (median survival, 31.9 months). Multivariable analysis demonstrated a higher risk of death with increasing age, poorly differentiated tumors, involved margins, and nodal or distant metastases. Overall survival remained unchanged from 1985 to 2000 (P = .08). CONCLUSIONS: ACC carries a poor prognosis for patients commonly presenting with large, locally invasive tumors, involved margins, and metastatic disease. Survival is not affected by size but is diminished with increasing age, poorly differentiated tumors, involved margins, and the presence of regional and distant disease. Identification of novel therapies may help to increase survival, which has remained unchanged over the last 20 years.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Analysis of the SEER database gives a slightly older mean age of 55 years (11).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“However, in the United States, 45% of adrenalectomies for ACC are performed in community hospitals, 30% in academic centers, and only 15% in National Cancer Institute-designated Cancer Centers, suboptimal treatment of a rare and aggressive disease requiring specialized knowledge of surgical technique (11).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“an analysis of almost 4000 patients from the National Cancer Data Base, which found that 9% of ACC patients treated with surgery had microscopically positive margins (R1), whereas a further 10% had macroscopically positive margins (R2) (11).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“The outcomes after surgical resection alone have remained suboptimal (11, 244, 267, 269–273).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“patients with positive margins had a dismal prognosis compared with those with uninvolved margins; 5-year survival was 10% after R2 resection, 21% after R1, and 49% after R0 (11).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“ACC has a well-documented propensity for lymphatic dissemination (11, 91, 351), with involved nodal disease in approximately 15% to 27% of patients at the time of surgery (11, 91).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“In the United States, it is used in approximately 10% of cases, according to analyses of both the National Cancer Data Base and the SEER program (4, 11, 90).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10 · Cited by 2,097
Spiess, P. E., Lee, A. K., Leibovici, D., Wang, X., Do, K.-A., & Pisters, L. L. (2006) · Cancer · doi:10.1002/cncr.21979 · Cited by 1,930
The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States
Bilimoria, K. Y., Stewart, A. K., Winchester, D. P., & Ko, C. Y. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9747-3 · Cited by 1,853
Self-citationComparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors
Weiss, L. M. (1984) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198403000-00001 · Cited by 920
Adrenocortical Carcinoma: Clinical Update
Allolio, B., & Fassnacht, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2639 · Cited by 775
Adjuvant Mitotane Treatment for Adrenocortical Carcinoma
Terzolo, M., Angeli, A., Faßnacht, M., Daffara, F., Tauchmanovà, L., Conton, P. A., Rossetto, R., Buci, L., Sperone, P., Grossrubatscher, E. M., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063360 · Cited by 759
Icard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Flagged first, then by citations
Research works printed but not linked: 3
- 1990, International Classification of Disease for Oncology
- 2000, International Classification of Disease for Oncology
- 2004, Facility Oncology Registry Data Standards
Cited by
Sorted by citations
Items 201–300 of 494
Margonis, G. A., Amini, N., Kim, Y., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Evans, D. B., Hatzaras, I. S., Shenoy, R. S., et al. (2015) · World Journal of Surgery · doi:10.1007/s00268-015-3307-y · Cited by 17
Regional Lymphadenectomy for Adrenocortical Carcinoma
Miller, B. S., & Doherty, G. M. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182891ee5 · Cited by 17
Wu, K., Liu, X., Liu, Z., Lu, Y., Wang, X., & Li, X. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.7035 · Cited by 16
Adrenocortical carcinoma: What the surgeon needs to know. Case report and literature review
Benassai, G., Desiato, V., Benassai, G., Bianco, T., Sivero, L., Compagna, R., Vigliotti, G., Limite, G., Amato, B., & Quarto, G. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.05.030 · Cited by 16
Disparities in access to care and outcomes in patients with adrenocortical carcinoma
Hammad, A. Y., Yen, T. W. F., Carr, A. A., Evans, D. B., & Wang, T. S. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.02.046 · Cited by 16
Panizzo, V., Rubino, B., Piozzi, G. N., Ubiali, P., Morandi, A., Nencioni, M., & Micheletto, G. (2018) · American Journal of Case Reports · doi:10.12659/ajcr.910259 · Cited by 16
Histopathologic Features of Adrenal Cortical Carcinoma
Gambella, A., Volante, M., & Papotti, M. G. (2022) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000363 · Cited by 16
Gaujoux, S., Bonnet, S., & Dousset, B. E. (2010) · European Urology · doi:10.1016/j.eururo.2010.09.001 · Cited by 16
Adrenocortical Carcinoma: Clinicopathological Features, Prognostic Factors and Outcome
Keskın, S., Taş, F., & Vatansever, S. (2013) · Urologia Internationalis · doi:10.1159/000345489 · Cited by 15
Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options
Al-Ward, R., Zsembery, C., & Habra, M. A. (2022) · Endocrine Oncology · doi:10.1530/eo-22-0050 · Cited by 15
van Bokhorst, K. L., Galac, S., Kooistra, H. S., de Grauw, J. C., Teske, E., Grinwis, G. C. M., & van Nimwegen, S. A. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1156801 · Cited by 15
Baechle, J. J., Smith, P. M., Solórzano, C. C., Tran, T. B., Postlewait, L. M., Maithel, S. K., Prescott, J. D., Pawlik, T. M., Wang, T. S., Glenn, J. A., et al. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-020-09562-8 · Cited by 15
TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas
Gupta, S., Won, H. H., Chadalavada, K., Nanjangud, G. J., Chen, Y., Al‐Ahmadie, H. A., Fine, S. W., Sirintrapun, S. J., Strong, V. E. M., Raj, N. P., et al. (2021) · Endocrine Pathology · doi:10.1007/s12022-021-09691-0 · Cited by 15
Loco-Regional Therapies in Oligometastatic Adrenocortical Carcinoma
Roux, C., Boilève, A., Faron, M., Lamartina, L., Delpla, A., Tselikas, L., Durand-Labrunie, J., Hescot, S., de Baère, T., Hadoux, J., et al. (2022) · Cancers · doi:10.3390/cancers14112730 · Cited by 15
Anderson, K. L., Adam, M. A., Thomas, S. M., Youngwirth, L. M., Stang, M. T., Scheri, R. P., Roman, S. A., & Sosa, J. A. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6398-5 · Cited by 15
Venous thromboembolism in patients with adrenocortical carcinoma after surgery
Durmuşoğlu, J., Timmers, H. J. L. M., van Houten, P., Langenhuijsen, H. F., Hermus, A. R., & van de Ven, A. C. (2020) · Endocrine Connections · doi:10.1530/ec-20-0299 · Cited by 15
Poorman, C. E., Postlewait, L. M., Ethun, C. G., Tran, T. B., Prescott, J. D., Pawlik, T. M., Wang, T. S., Glenn, J. A., Hatzaras, I. S., Shenoy, R. S., et al. (2017) · The American Surgeon · doi:10.1177/000313481708300735 · Cited by 14
Mauda‐Havakuk, M., Levin, E., Levy, E. B., Krishnasamy, V. P., Anderson, V., Jain, N., Amalou, H., Fojo, T., Edgerly, M., Wakim, P., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3740 · Cited by 14
Gaitanidis, A., Wiseman, D., Lakis, M. E., Nilubol, N., Kebebew, E., & Patel, D. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25760 · Cited by 14
Self-citationOpen versus minimally invasive surgery for suspected adrenocortical carcinoma
Buller, D. M., Hennessey, A. M., & Ristau, B. T. (2021) · Translational Andrology and Urology · doi:10.21037/tau.2020.01.11 · Cited by 15
Minimally Invasive Surgery for Resectable Adrenocortical Carcinoma: A Nationwide Analysis
Delman, A. M., Turner, K. M., Griffith, A. Y., Schepers, E. J., Ammann, A. M., & Holm, T. M. (2022) · Journal of Surgical Research · doi:10.1016/j.jss.2022.04.078 · Cited by 13
Liu, L., Yang, M., & Chen, Z. (2024) · Drug Delivery · doi:10.1080/10717544.2024.2390022 · Cited by 13
Prognostic factors in adrenocortical carcinoma: data from a large Polish series
Nowak, K. M., Samsel, R., Cichocki, A. S., Ambroziak, U., Roszkowska‐Purska, K., Łebek-Szatańska, A., Koperski, Ł., Otto, M., Zgliczyński, W., & Papierska, L. (2018) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.4260 · Cited by 13
Molecular genomic profiling of adrenocortical cancers in clinical practice
Darabi, S., Braxton, D. R., Eisenberg, B. L., & Demeure, M. J. (2020) · Surgery · doi:10.1016/j.surg.2020.05.039 · Cited by 13
Deutsches Nebennierenrindenkarzinom-Register
Reibetanz, J., Kroiß, M., Deutschbein, T., Fenske, W., Gasser, M., Jurowich, C. F., Germer, C.-T., Allolio, B., & Faßnacht, M. (2012) · Der Chirurg · doi:10.1007/s00104-011-2193-6 · Cited by 13
Bellantone, R. D. A., Lombardi, C. P., & Raffaelli, M. (2014) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000144 · Cited by 13
Laparoscopic or Open Adrenalectomy for Stage I–II Adrenocortical Carcinoma: A Retrospective Study
Gaillard, M., Razafinimanana, M., Challine, A., Araújo, R. L. C., Libé, R., Sibony, M., Barat, M., Bertherat, J. Y., Dousset, B. E., Fuks, D., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113698 · Cited by 12
Pereira, B. D., Rios, E., Cabrera, R., Portugal, J., & Raimundo, L. (2014) · Endocrine Pathology · doi:10.1007/s12022-014-9325-8 · Cited by 12
Analysis of IGF and IGFBP as Prognostic Serum Biomarkers for Adrenocortical Carcinoma
Patel, D., Ellis, R. J., Howard, B., Boufraqech, M., Gara, S. K., Zhang, L., Quezado, M., Nilubol, N., & Kebebew, E. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3768-5 · Cited by 12
Self-citationPrognostic significance of immunohistochemical markers in adrenocortical carcinoma
Loncar, Z. M., Paunovic, I. R., Zivaljevic, V. R., Dundjerović, D., Tatic, S. B., & Djukić, V. (2018) · Acta chirurgica Belgica · doi:10.1080/00015458.2018.1543822 · Cited by 12
Ayabe, R. I., Narayan, R. R., Ruff, S. M., Wach, M. M., Lo, W. M., Nierop, P. M. H., Steinberg, S. M., Ripley, R. T., Davis, J. L., Koerkamp, B. G., et al. (2019) · HPB · doi:10.1016/j.hpb.2019.07.002 · Cited by 12
Mitotane Targets Lipid Droplets to Induce Lipolysis in Adrenocortical Carcinoma
Warde, K. M., Lim, Y. J., Martínez, E. R., Beuschlein, F., O’Shea, P. M., Hantel, C., & Dennedy, M. C. (2022) · Endocrinology · doi:10.1210/endocr/bqac102 · Cited by 12
Ganeshan, D., Bhosale, P., & Kundra, V. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.8282 · Cited by 12
Yin, M., Wang, Y., Ren, X., Han, M., Li, S., Liang, R., Wang, G., & Gang, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1250033 · Cited by 11
Balderrama-Brondani, V., Montenegro, L. R., Lacombe, A. M. F., Magalhães, B. M., Nishi, M. Y., Funari, M. F. A., Narcizo, A. D. M., Cardoso, L. C., Siqueira, S. A. C., Zerbini, M. C. N., et al. (2020) · Cancers · doi:10.3390/cancers12030621 · Cited by 11
Tian, X., Xu, W., Anwaier, A., Wang, H., Wan, F., Cao, D., Luo, W., Shi, G., Qu, Y., Zhang, H., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16323 · Cited by 11
The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma
Ma, C., Xiong, J. P., Su, H., & Li, H. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.60261 · Cited by 11
de Pádua, T. C., Marandino, L., Raggi, D., Johnson, J. E. H., Kutikov, A., Spiess, P. E., & Necchi, A. (2022) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2022.10.011 · Cited by 11
Laparoscopic adrenalectomy for adrenocortical carcinoma: A medico-surgical perspective
Gaujoux, S., Bertherat, J. Y., Dousset, B. E., & Groussin, L. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.07.001 · Cited by 11
Werner, R. A., Kroiß, M., Nakajo, M., Mügge, D. O., Hahner, S., Faßnacht, M., Schirbel, A., Bluemel, C., Higuchi, T., Papp, L., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0970-1 · Cited by 11
MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma
Detomas, M., Pivonello, C., Pellegrini, B., Landwehr, L., Sbiera, S., Pivonello, R., Ronchi, C. L., Colao, A., Altieri, B., & Martino, M. C. D. (2022) · Cells · doi:10.3390/cells11142234 · Cited by 11
Tiberio, G. A. M., Ferrari, V. D., Ballarini, Z., Casole, G., Laganà, M., Gritti, M., Arici, E., Grisanti, S., Nascimbeni, R., Sigala, S., et al. (2020) · Cancers · doi:10.3390/cancers12040969 · Cited by 10
Akın, O., Ataş, E., Atasoy, İ. A., Durmaz, N., & Kartal, Ö. (2020) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2020.2020.0060 · Cited by 10
Adrenocortical Carcinoma: Modern Management and Evolving Treatment Strategies
McDuffie, L. A., & Aufforth, R. (2016) · International Journal of Endocrine Oncology · doi:10.2217/ije-2015-0003 · Cited by 10
Asadi, A. A., Hubbs, D., Sweigert, P. J., Baker, M. S., & Kabaker, A. S. (2020) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2020.10.038 · Cited by 10
Cancer of the Endocrine System
Asban, A. A., Patel, A. J., Reddy, S., Wang, T., Balentine, C. J., & Chen, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00068-2 · Cited by 10
Preoperative adrenal biopsy does not affect overall survival in adrenocortical carcinoma
Suman, P., Calcatera, N. A., Wang, C., Moo‐Young, T. A., Winchester, D. J., & Prinz, R. A. (2017) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2017.01.039 · Cited by 10
Self-citationEttaieb, M. H. T., van Kuijk, S. M. J., de Wit-Pastoors, A., Feelders, R. A., Corssmit, E. P. M., Eekhoff, E. M. W., van der Valk, P., Timmers, H. J. L. M., Kerstens, M. N., Klümpen, H., et al. (2020) · Cancers · doi:10.3390/cancers12092720 · Cited by 10
Akhavanfard, S., Yehia, L., Padmanabhan, R., REYNOLDS, J. P., Ni, Y., & Eng, C. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa268 · Cited by 10
A Pregnant Patient with Adrenocortical Carcinoma: Case Report
Kotteas, E. A., Ioachim, E., & Pavlidis, N. A. (2012) · Onkologie · doi:10.1159/000341830 · Cited by 10
Cioppi, F., Cantini, G., Ercolino, T., Chetta, M., Zanatta, L., Nesi, G., Mannelli, M., Maggi, M., Canu, L., & Luconi, M. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae077 · Cited by 9
Balla, A., Corallino, D., Ortenzi, M., Palmieri, L., Meoli, F., Guerrieri, M., & Paganini, A. M. (2021) · Surgical Endoscopy · doi:10.1007/s00464-021-08380-7 · Cited by 9
Fu, Y., Sun, S., Bi, J., Kong, C., & Yin, L. (2021) · Medicine · doi:10.1097/md.0000000000025031 · Cited by 9
Thomas, J. J., & Tward, J. D. (2021) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2021.03.009 · Cited by 9
Chemotherapy for advanced adrenal cancer: improvement from a molecular approach?
Costa, R., Wesolowski, R., & Raghavan, D. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10464.x · Cited by 9
Sharma, P., Soundararajan, R., Patnecha, M., Lata, S., Kumar, R., & Malholtra, A. (2013) · Diagnostic and Interventional Radiology · doi:10.5152/dir.2013.048 · Cited by 9
Yeh, M. W., & Duh, Q. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1560-6.00041-x · Cited by 9
Zhang, H., Naji, Y., Yan, M., Lian, W., Xie, M., & Dai, Y. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02413-1 · Cited by 9
Current issues in the diagnosis and management of adrenocortical carcinomas
Kassi, E. N., Kaltsas, G., Zografos, G., & Chrousos, G. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.6 · Cited by 9
A Case of Hemorrhagic Adrenal Pseudocyst Mimicking Solid Tumor
Isono, M., Ito, K., Seguchi, K., Kimura, T., Tachi, K., Kono, T., Shinmoto, H., & Asano, T. (2017) · American Journal of Case Reports · doi:10.12659/ajcr.905063 · Cited by 9
Minimally Invasive Adrenal Surgery: Virtue or Vice?
Winoker, J. S., Ahlborn, D., Omidele, O. O., Fernandez-Ranvier, G. G., Derweesh, I., & Mehrazin, R. (2018) · Future Oncology · doi:10.2217/fon-2017-0420 · Cited by 9
Soon, P. S. H., & Sidhu, S. B. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0857-5_11 · Cited by 9
Prognostic predictors of adrenocortical carcinoma: A single-center thirty-year experience
Pan, L.-H., Yen, C., Huang, C.-J., Ng, X.-N., & Lin, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1134643 · Cited by 8
Indoleamine 2,3-Dioxygenase-1 Expression in Adrenocortical Carcinoma
Tierney, J. F., Vogle, A., Finnerty, B. M., Zarnegar, R., Ghai, R., Gattuso, P., Fahey, T. J., & Keutgen, X. M. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.06.016 · Cited by 8
Ding, G., Liu, S., Ding, Q., & Feng, C. (2017) · Oncotarget · doi:10.18632/oncotarget.22827 · Cited by 8
Spanish consensus on the diagnosis and management of adrenocortical carcinoma
Castro, M. A., Álvarez-Escolá, C., Casteràs, A., Carmona‐Bayonas, A., Chiara, M., Hanzu, F. A., Hernando, J., Vercher-Conejero, J. L., Rodríguez‐Fraile, M., Santos, V. G. D., et al. (2025) · Endocrine Related Cancer · doi:10.1530/erc-25-0034 · Cited by 7
Oncogene or tumor suppressor gene: An integrated pan-cancer analysis of NBPF1
Li, L., Chen, S., Tang, Y., Wu, J., He, Y., & Qiu, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.950326 · Cited by 7
Establishment of prognostic models of adrenocortical carcinoma using machine learning and big data
Tang, J., Yu, F., & Xu, Z. (2023) · Frontiers in Surgery · doi:10.3389/fsurg.2022.966307 · Cited by 7
Ishikawa, Y., Yamazaki, Y., Tezuka, Y., Omata, K., Ono, Y., Tokodai, K., Fujishima, F., Kawanabe, S., Katabami, T., Ikeya, A., et al. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106462 · Cited by 7
Chahla, B., Pal, K., Balderrama-Brondani, V., Yaylaci, F., Campbell, M. T., Sheth, R. A., & Habra, M. A. (2024) · The Oncologist · doi:10.1093/oncolo/oyae130 · Cited by 7
Which lymphadenectomy for adrenocortical carcinoma?
de Ponthaud, C., Bekada, S., Buffet, C., Roy, M., Bachelot, A., Ayed, A., Ménégaux, F., & Gaujoux, S. (2024) · Surgery · doi:10.1016/j.surg.2024.09.008 · Cited by 7
Uruç, F., Ürkmez, A., Yüksel, Ö. H., Şahin, A., & Verit, A. (2015) · Canadian Urological Association Journal · doi:10.5489/cuaj.2867 · Cited by 7
Wilson, B. M., Tseng, C., Soroka, O., POGACH, L. M., & Aron, D. C. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2692-3 · Cited by 7
The prognostic significance of adrenocortical carcinomas identified incidentally
Rossfeld, K. K., Maithel, S. K., Prescott, J. D., Wang, T. S., Fields, R. C., Weber, S. M., Sicklick, J. K., Yopp, A. C., Duh, Q., Solórzano, C. C., et al. (2018) · Journal of Surgical Oncology · doi:10.1002/jso.25274 · Cited by 7
Risk factors associated with positive resection margins in patients with adrenocortical carcinoma
Skertich, N. J., Tierney, J. F., Chivukula, S. V., Babazadeh, N. T., Hertl, M., Poirier, J., & Keutgen, X. M. (2020) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2020.02.043 · Cited by 7
David, S. O., Krieg, S., Esposito, I., Schott, M., Giesel, F. L., Roderburg, C., Loosen, S. H., Luedde, T., Knoefel, W. T., & Krieg, A. H. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2042-2431 · Cited by 7
Surgical management of metastatic adrenocortical carcinoma
Passman, J. E., Amjad, W., Ginzberg, S. P., Ballester, J. M. S., Finn, C. B., & Wachtel, H. (2023) · World Journal of Surgery · doi:10.1002/wjs.12014 · Cited by 7
Elfiky, A. A. (2015) · Surgical pathology clinics · doi:10.1016/j.path.2015.07.002 · Cited by 7
Bronswijk, M. J., Laenen, A., & Bechter, O. E. (2019) · Neoplasma · doi:10.4149/neo_2019_190105n17 · Cited by 7
Nomograms for the Prediction of Survival for Patients with Pediatric Adrenal Cancer after Surgery
Zheng, J., Cai, J., Diao, X., Kong, J., Chen, X., Yu, H., Xie, W., Huang, J., & Lin, T. (2020) · Journal of Cancer · doi:10.7150/jca.36861 · Cited by 7
Kaštelan, D., Muzurović, E. M., & Dušek, T. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000626 · Cited by 7
Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
Liang, W., & Sun, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.538364 · Cited by 7
Zhang, F., Liu, Z., Liang, J., Liu, S., Wu, K., Zhang, F., Zhou, C., Lu, Y., Zhu, Y., & Wang, X. (2021) · BMC Cancer · doi:10.1186/s12885-021-08689-5 · Cited by 7
Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma
Michalski, K., Schlötelburg, W., Hartrampf, P. E., Kosmala, A., Buck, A. K., Hahner, S., & Schirbel, A. (2023) · Pharmaceuticals · doi:10.3390/ph17010025 · Cited by 6
Expression Patterns of MOTS-c in Adrenal Tumors: Results from a Preliminary Study
Kamiński, K., Blatkiewicz, M., Szyszka, M., Olechnowicz, A., Komarowska, H., Klimont, A., Wierzbicki, T., Karczewski, M., Ruchała, M., & Ruciński, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168721 · Cited by 6
Carmona‐Bayonas, A., Álvarez-Escolá, C., Navarro, I. B., Hernando, J., Cruz, M. Á. M., García-Centeno, R., Iglesias, C., García-Donás, J., César, M. J. P., Paja, M., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf082 · Cited by 6
Atallah, S., Alassaf, H., Xu, Y., & El-Sayed, S. M. (2017) · Current Oncology · doi:10.3747/co.24.3533 · Cited by 6
Kwok, G., Zhao, J., Glover, A. R., Ip, J. C. Y., Sywak, M. S., Clifton-Bligh, R. J., Clarke, S. J., Robinson, B. G., & Sidhu, S. B. (2019) · ANZ Journal of Surgery · doi:10.1111/ans.15032 · Cited by 6
Radiation treatment for adult rare cancers: Oldest and newest indication
Fiorentino, A., Gregucci, F., Desideri, I., Fiore, M., Marino, L., Errico, A., Rito, A. D., Borghetti, P., Franco, P., Greto, D., et al. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103228 · Cited by 6
Ginsburg, K., Bigalli, A. A. C., Schober, J. P., Perlman, D., Handorf, E. A., Chen, D. Y. T., Greenberg, R. E., Viterbo, R., Uzzo, R. G., Kutikov, A., et al. (2022) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2022.05.021 · Cited by 6
Inflammation-based scores as predictors of treatment response in advanced adrenocortical carcinoma
Mangone, A., Altieri, B., Detomas, M., Prete, A., Abbas, H., Asia, M. F., Elhassan, Y., Mantovani, G., & Ronchi, C. L. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0372 · Cited by 6
Feminizing Adrenocortical Carcinoma with Distant Metastases: Can Surgery Be Considered?
Fancellu, A., Pinna, A., & Porcu, A. (2014) · Clinics and Practice · doi:10.4081/cp.2014.651 · Cited by 6
Construction of a risk signature for adrenocortical carcinoma using immune-related genes
Fu, Y., Sun, S., Bi, J., & Kong, C. (2020) · Translational Andrology and Urology · doi:10.21037/tau-20-485 · Cited by 6
Amodru, V., Garcia, M.-E., Libé, R., Brue, T. C., Reznik, Y., & Castinetti, F. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.12.003 · Cited by 6
Plant Natural Compounds in the Treatment of Adrenocortical Tumors
Manso, J., Sharifi‐Rad, J., Zam, W., Fokou, P. V. T., Martorell, M., & Pezzani, R. (2021) · International Journal of Endocrinology · doi:10.1155/2021/5516285 · Cited by 6
Defining Optimal Management of Non-metastatic Adrenocortical Carcinoma
Passman, J. E., Amjad, W., Ballester, J. M. S., Ginzberg, S. P., & Wachtel, H. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-14533-w · Cited by 6
Resektionsstrategie bei Nebennierenrindenkarzinomen
Schimmack, S. J., & Strobel, O. (2018) · Der Chirurg · doi:10.1007/s00104-018-0712-4 · Cited by 6
Zheng, G., Zhang, X., Li, H., Zhang, Y., Deng, J., & Wu, X. (2021) · Biochemical Genetics · doi:10.1007/s10528-021-10039-w · Cited by 6
Surgery of adrenocortical cancer
Harrison, B. J. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.02.003 · Cited by 6
Ronchi, C. L., Sbiera, S., Leich, E., Rosenwald, A., Allolio, B., & Faßnacht, M. (2013) · Endocrine Abstracts · doi:10.1530/endoabs.32.oc4.2 · Cited by 6
Metadata
- Authors
- Bilimoria, K. Y., Shen, W. T., Elaraj, D., Bentrem, D. J., Winchester, D. J., Kebebew, E., & Sturgeon, C.
- Affiliations
- Northwestern University (US)
- University of California, San Francisco (US)
- Corresponding author
- Bilimoria, Karl Y.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-10-30
- Volume
- 113
- Issue
- 11
- Pages
- 3130-3136
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1994325777
- Cited by
- 493
- References
- 22
- Citations by year
- 2026: 17 · 2025: 24 · 2024: 29 · 2023: 28 · 2022: 28 · 2021: 45 · 2020: 39 · 2019: 29 · 2018: 39 · 2017: 31 · 2016: 26 · 2015: 35 · 2014: 24 · 2013: 19 · 2012: 29
- FWCI
- 17.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- adrenocortical carcinoma, adrenalectomy, surgical resection, long-term survival, prognostic factors, tumor differentiation, positive resection margins, lymph node metastasis, distant metastasis, adjuvant chemotherapy, adjuvant radiotherapy, treatment utilization, age at diagnosis
- MeSH terms
- Adrenal Cortex Neoplasms, Adult, Aged, Female, Humans, Male, Middle Aged, Prognosis, Registries, United States, Survival Analysis, Treatment Outcome, Adrenocortical Carcinoma, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
